It's OK six star creatine x3 tablets review The higher-than-expected earnings number reflected lowercosts, including reductions in spending on research anddevelopment (R&D) as several expensive late-stage clinicaltrials reached a conclusion. Witty said the trend of lower R&Dcosts was likely to continue into 2014.